Showing results (221-230 of 395) with videos related to
Sort By:
Pageof 40
Journal of Neurovirology|December 21, 2016
Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, UgandaMahsa Abassi, Bozena M Morawski, Gertrude Nakigozi, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 19, 2009
Diagnostic performance of rapid diagnostic tests versus blood smears for malaria in US clinical practiceWilliam M Stauffer, Charles P Cartwright, Douglas A Olson, et al.Plos Medicine|January 22, 2011
Clinical features and serum biomarkers in HIV immune reconstitution inflammatory syndrome after cryptococcal meningitis: a prospective cohort studyDavid R Boulware, David B Meya, Tracy L Bergemann, et al.Medical Mycology|April 28, 2021
High prevalence of Cryptococcal antigenemia using a finger-prick lateral flow assay in individuals with advanced HIV disease in Santarém Municipality, Brazilian Amazon BasinJoão Guilherme Pontes Lima Assy, Renato do Carmo Said, Olivia Campos Pinheiro, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 7, 2025
Predictive value of C-reactive protein for hospitalization and mortality among people with advanced HIV disease in Uganda receiving the WHO-recommended package of careElizabeth L Schwartz, Elizabeth K Nalintya, Caleb P Skipper, et al.Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Divergent Neuroimmune Signatures in the Cerebrospinal Fluid Predict Differential Gender-Specific Survival Among Patients With HIV-Associated Cryptococcal MeningitisSamuel Okurut, David R Boulware, Elizabeth Okafor, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|November 7, 2018
Reflexive Laboratory-Based Cryptococcal Antigen Screening and Preemptive Fluconazole Therapy for Cryptococcal Antigenemia in HIV-Infected Individuals With CD4 <100 Cells/µL: A Stepped-Wedge, Cluster-Randomized TrialDavid B Meya, Agnes N Kiragga, Elizabeth Nalintya, et al.Wellcome Open Research|August 12, 2022
Neurocognitive outcomes of tuberculous meningitis in a primarily HIV-positive Ugandan cohortCarson M Quinn, John Kasibante, Alice Namudde, et al.Journal of Research in Nursing : JRN|August 16, 2021
The conundrum of clinical trials and standard of care in sub-Saharan Africa - the research nurse perspectiveJane Frances Ndyetukira, Richard Kwizera, Florence Kugonza, et al.Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|November 6, 2025
Valganciclovir for cytomegalovirus viraemia in advanced HIV disease: a phase 2b randomized placebo-controlled trial of valganciclovir for cytomegalovirus viraemia in adults and adolescents with advanced HIV diseaseJayne Ellis, Laura Joan Nsangi, Mohammed Rassool, et al.Pageof 40